Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: an European organisation for research and treatment of cancer soft tissue and bone sarcoma group randomised phase II and pharmacogenetic study - Gelderblom, Hans R.; Hohenberger, Peter (European journal of cancer, 2014)
Gesehen am 07.10.2014